Current diagnostics in NSAID hypersensitivity

[1]  J. Perkins,et al.  Natural evolution in patients with nonsteroidal anti‐inflammatory drug‐induced urticaria/angioedema , 2017, Allergy.

[2]  Kenneth H. Lai,et al.  Adverse and Hypersensitivity Reactions to Prescription Nonsteroidal Anti-Inflammatory Agents in a Large Health Care System. , 2017, The journal of allergy and clinical immunology. In practice.

[3]  D. Ebo,et al.  In Vitro Diagnosis of Immediate Drug Hypersensitivity Anno 2017: Potentials and Limitations , 2017, Drugs in R&D.

[4]  A. Romano,et al.  Clinical approach on challenge and desensitization procedures with aspirin in patients with ischemic heart disease and nonsteroidal anti‐inflammatory drug hypersensitivity , 2017, Allergy.

[5]  A. Trautmann,et al.  H1-Antihistamine Premedication in NSAID-Associated Urticaria. , 2016, The journal of allergy and clinical immunology. In practice.

[6]  H. Suryapranata,et al.  Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols. , 2016, Vascular pharmacology.

[7]  M. Blanca,et al.  ASA must be given to classify multiple NSAID‐hypersensitivity patients as selective or cross‐intolerant , 2016, Allergy.

[8]  J. Perkins,et al.  Pyrazolones metabolites are relevant for identifying selective anaphylaxis to metamizole , 2016, Scientific Reports.

[9]  B. Rotenberg,et al.  A novel treatment adjunct for aspirin exacerbated respiratory disease: the low‐salicylate diet: a multicenter randomized control crossover trial , 2016, International forum of allergy & rhinology.

[10]  T. Zuberbier,et al.  Guidelines on the management of IgE-mediated food allergies , 2015, Allergo Journal International.

[11]  S. Büyüköztürk,et al.  Evaluation of hypersensitivity reactions to nonsteroidal anti‐inflammatory drugs according to the latest classification , 2015, Allergy.

[12]  M. Kowalski,et al.  Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema. , 2015, The Journal of allergy and clinical immunology.

[13]  J. Perkins,et al.  Genetic basis of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs , 2015, Current opinion in allergy and clinical immunology.

[14]  N. Moore,et al.  Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs , 2015, Therapeutics and clinical risk management.

[15]  H. Sitter,et al.  Guideline for the diagnosis of drug hypersensitivity reactions , 2015, Allergo Journal International.

[16]  M. Sánchez-Borges,et al.  Aspirin‐exacerbated cutaneous disease (AECD) is a distinct subphenotype of chronic spontaneous urticaria , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[17]  C. Saçkesen,et al.  Challenge‐proven aspirin hypersensitivity in children with chronic spontaneous urticaria , 2015, Allergy.

[18]  K. Brockow,et al.  Non-steroidal anti-inflammatory drug hypersensitivity: association with elevated basal serum tryptase? , 2014, Allergy, Asthma & Clinical Immunology.

[19]  M. Morais‐Almeida,et al.  Drug-induced anaphylaxis survey in Portuguese Allergy Departments. , 2014, Journal of investigational allergology & clinical immunology.

[20]  T. Biedermann,et al.  Anaphylaxis: opportunities of stratified medicine for diagnosis and risk assessment , 2013, Allergy.

[21]  S. Kaesler,et al.  About the role and underlying mechanisms of cofactors in anaphylaxis , 2013, Allergy.

[22]  M. Worm,et al.  [The registry for severe allergic reactions in German-speaking countries. Recent data and perspectives]. , 2012, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[23]  M. Worm,et al.  Das deutschsprachige Anaphylaxie-Register , 2012, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[24]  P. Bousquet,et al.  Evaluating the negative predictive value of provocation tests with nonsteroidal anti‐inflammatory drugs , 2011, Allergy.

[25]  J. Bousquet,et al.  Hypersensitivity to nonsteroidal anti‐inflammatory drugs (NSAIDs) – classification, diagnosis and management: review of the EAACI/ENDA # and GA2LEN/HANNA * , 2011, Allergy.

[26]  J. Kyle,et al.  A systematic review of salicylates in foods: estimated daily intake of a Scottish population. , 2011, Molecular nutrition & food research.

[27]  B. Thong,et al.  Epidemiology and risk factors for drug allergy. , 2011, British journal of clinical pharmacology.

[28]  W. Aberer,et al.  Diclofenac Hypersensitivity: Antibody Responses to the Parent Drug and Relevant Metabolites , 2010, PloS one.

[29]  A. Kapp,et al.  Zelluläre In-vitro-Allergiediagnostik , 2010, Der Hautarzt.

[30]  B. Wedi.  Definitions and mechanisms of drug hypersensitivity , 2010, Expert review of clinical pharmacology.

[31]  T. Mersfelder,et al.  Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature. , 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[32]  M. Kowalski,et al.  Nonsteroidal anti-inflammatory drug hypersensitivity syndrome: a multicenter study. II. Basophil activation by nonsteroidal anti-inflammatory drugs and its impact on pathogenesis. , 2010, Journal of investigational allergology & clinical immunology.

[33]  M. Kowalski,et al.  Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis. , 2009, Journal of investigational allergology & clinical immunology.

[34]  S. Kountakis,et al.  The Prevalence of Samter's Triad in Patients Undergoing Functional Endoscopic Sinus Surgery , 2007, Ear, nose, & throat journal.

[35]  B. Wedi,et al.  Symposium 7: Zelluläre In-vitro-Diagnostik , 2007 .

[36]  T. Carrillo,et al.  Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions. , 2007, Journal of investigational allergology & clinical immunology.

[37]  S. Shakir,et al.  Serious Skin Reactions and Selective COX-2 Inhibitors , 2006, Drug safety.

[38]  P. Demoly,et al.  Epidemiology of hypersensitivity drug reactions , 2005 .

[39]  R. Asero.  Oral aspirin challenges in patients with a history of intolerance to single non‐steroidal anti‐inflammatory drugs , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[40]  A. D. de Weck,et al.  The flow‐cytometric determination of basophil activation induced by aspirin and other non‐steroidal anti‐inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[41]  Z. Erbagci.  Multiple NSAID Intolerance in Chronic Idiopathic Urticaria Is Correlated with Delayed, Pronounced and Prolonged Autoreactivity , 2004, The Journal of dermatology.

[42]  C. Jenkins,et al.  Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice , 2004, BMJ : British Medical Journal.

[43]  R. Stern,et al.  The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective. , 2003, The Journal of rheumatology.

[44]  R. Mullins,et al.  Anaphylaxis: risk factors for recurrence , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[45]  U. Jappe,et al.  In-vitro-Allergiediagnostik , 2003 .

[46]  C. Grattan.  Aspirin sensitivity and urticaria , 2003, Clinical and experimental dermatology.

[47]  E. Novembre,et al.  Clinical features of acute anaphylaxis in patients admitted to a university hospital: an 11-year retrospective review (1985-1996). , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[48]  R. Garavito,et al.  Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.

[49]  F. Martín-Muñoz,et al.  Evaluation of drug-related hypersensitivity reactions in children. , 1999, Journal of investigational allergology & clinical immunology.

[50]  A. Kapp,et al.  Wertigkeit des zellulären Antigenstimulationstests (CAST) , 1997, Der Hautarzt.

[51]  L. Naldi,et al.  Cutaneous reactions to analgesic-antipyretics and nonsteroidal anti-inflammatory drugs. Analysis of reports to the spontaneous reporting system of the Gruppo Italiano Studi Epidemiologici in Dermatologia. , 1993, Dermatology.

[52]  M. Greaves,et al.  Pharmacology and significance of nonsteroidal anti-inflammatory drugs in the treatment of skin diseases. , 1987, Journal of the American Academy of Dermatology.